{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:27:48Z","timestamp":1787020068381,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autoimmune cytopenias (AICs) are among the most frequent non-infectious complications in inborn errors of immunity (IEIs) and may represent early or even initial manifestations. The genetic underpinnings of AICs in IEIs remain heterogeneous and incompletely defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to determine the prevalence and distribution of AICs and to investigate their associations with underlying monogenic mutations and selected immunophenotypic parameters in adult patients with IEI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 121 adult IEI patients from a single tertiary immunology center were evaluated retrospectively. Clinical, immunophenotypic, and genetic data were obtained from electronic medical records. Comparisons were made between patients with and without autoimmune manifestations and AICs. Monogenic mutations were identified using targeted next-generation sequencing (NGS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Autoimmune manifestations were present in 48 of 121 patients (39.6%), and autoimmune cytopenias (AICs) were identified in 33 patients (27.5%). Autoimmune hemolytic anemia (AIHA) was the most frequently observed subtype, followed by combined cytopenias and immune thrombocytopenia (ITP). The most common genetic alteration detected was a mutation in\n                      <jats:italic>TNFRSF13B<\/jats:italic>\n                      (TACI), with additional variants identified in\n                      <jats:italic>DOCK8<\/jats:italic>\n                      ,\n                      <jats:italic>RAG1<\/jats:italic>\n                      ,\n                      <jats:italic>LRBA<\/jats:italic>\n                      ,\n                      <jats:italic>PRF1<\/jats:italic>\n                      ,\n                      <jats:italic>PSTPIP1<\/jats:italic>\n                      ,\n                      <jats:italic>CECR1<\/jats:italic>\n                      ,\n                      <jats:italic>PRKDC<\/jats:italic>\n                      , and\n                      <jats:italic>MRTFA<\/jats:italic>\n                      . Logistic regression revealed a strong independent association between TACI mutations and ITP (OR: 46.5,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), while no significant relationship was found with autoimmune cytopenias overall. No statistically significant differences were found in class-switched memory B cells (CD27\u207aIgD\u207b) percentages, CD4\u207a\/CD8\u207a T-cell ratios, or baseline IgG concentrations between patients with and without autoimmune manifestations or AICs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AICs represent a significant clinical burden in adult IEIs and may occur in association with a wide range of genetic variants. Class-switched memory B cells (CD27\u207aIgD\u207b) percentages, CD4\u207a\/CD8\u207a T-cell ratio, and baseline IgG were not significantly associated with autoimmunity in this cohort. These findings underscore the need for broader immunophenotypic and genetic screening to improve the early recognition and management of autoimmune complications in IEIs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12865-025-00752-1","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:22:44Z","timestamp":1758705764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Autoimmune cytopenias in inborn errors of immunity: associations with monogenic mutations and immunologic parameters"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3752-8469","authenticated-orcid":false,"given":"Ferhat","family":"Sa\u011fun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6595-1267","authenticated-orcid":false,"given":"Fatih","family":"\u00c7\u00f6lkesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4792-0544","authenticated-orcid":false,"given":"Mehmet Emin","family":"Gerek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5582-4918","authenticated-orcid":false,"given":"\u015e\u00fckran Aslan","family":"Sava\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5406-3459","authenticated-orcid":false,"given":"Se\u00e7im","family":"Kolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1554-0419","authenticated-orcid":false,"given":"Emrah","family":"Harman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0343-0159","authenticated-orcid":false,"given":"\u015eevket","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"5","key":"752_CR1","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","volume":"136","author":"FA Bonilla","year":"2015","unstructured":"Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136(5):1186\u2013205.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"752_CR2","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","volume":"148","author":"J Thalhammer","year":"2021","unstructured":"Thalhammer J, Kindle G, Nieters A, Rusch S, Sepp\u00e4nen MRJ, Fischer A, et al. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol. 2021;148(5):1332\u2013e415.","journal-title":"J Allergy Clin Immunol"},{"key":"752_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fimmu.2012.00189","volume":"3","author":"JC Podjasek","year":"2012","unstructured":"Podjasek JC, Abraham RS. Autoimmune cytopenias in common variable immunodeficiency. Front Immunol. 2012;3:189.","journal-title":"Front Immunol"},{"key":"752_CR4","doi-asserted-by":"publisher","first-page":"911385","DOI":"10.3389\/fimmu.2022.911385","volume":"13","author":"L Pacillo","year":"2022","unstructured":"Pacillo L, Giardino G, Amodio D, Giancotta C, Rivalta B, Rotulo GA, et al. Targeted treatment of autoimmune cytopenias in primary immunodeficiencies. Front Immunol. 2022;13:911385.","journal-title":"Front Immunol"},{"issue":"5","key":"752_CR5","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","volume":"140","author":"A Fischer","year":"2017","unstructured":"Fischer A, Provot J, Jais JP, Alcais A, Mahlaoui N. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2017;140(5):1388\u2013e938.","journal-title":"J Allergy Clin Immunol"},{"key":"752_CR6","doi-asserted-by":"publisher","first-page":"652487","DOI":"10.3389\/fimmu.2021.652487","volume":"12","author":"I Mormile","year":"2021","unstructured":"Mormile I, Punziano A, Riolo CA, Granata F, Williams M, de Paulis A, et al. Common variable immunodeficiency and autoimmune diseases: A retrospective study of 95 adult patients in a single tertiary care center. Front Immunol. 2021;12:652487.","journal-title":"Front Immunol"},{"key":"752_CR7","doi-asserted-by":"publisher","first-page":"649182","DOI":"10.3389\/fimmu.2021.649182","volume":"12","author":"E Westermann-Clark","year":"2021","unstructured":"Westermann-Clark E, Meehan CA, Meyer AK, Dasso JF, Amre D, Ellison M, et al. Primary immunodeficiency in children with autoimmune cytopenias: retrospective 154-Patient cohort. Front Immunol. 2021;12:649182.","journal-title":"Front Immunol"},{"issue":"12","key":"752_CR8","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/1744666X.2021.1850272","volume":"16","author":"FS Rizvi","year":"2020","unstructured":"Rizvi FS, Zainaldain H, Rafiemanesh H, Jamee M, Hossein-Khannazer N, Hamedifar H, et al. Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis. Expert Rev Clin Immunol. 2020;16(12):1227\u201335.","journal-title":"Expert Rev Clin Immunol"},{"key":"752_CR9","doi-asserted-by":"publisher","first-page":"790455","DOI":"10.3389\/fimmu.2021.790455","volume":"12","author":"E Schiavo","year":"2021","unstructured":"Schiavo E, Martini B, Attardi E, Consonni F, Ciullini Mannurita S, Coniglio ML, et al. Autoimmune cytopenias and dysregulated immunophenotype act as warning signs of inborn errors of immunity: results from a prospective study. Front Immunol. 2021;12:790455.","journal-title":"Front Immunol"},{"key":"752_CR10","doi-asserted-by":"publisher","first-page":"869466","DOI":"10.3389\/fimmu.2022.869466","volume":"13","author":"S Chawla","year":"2022","unstructured":"Chawla S, Barman P, Tyagi R, Jindal AK, Sharma S, Rawat A, et al. Autoimmune cytopenias in common variable immunodeficiency are a diagnostic and therapeutic conundrum: an update. Front Immunol. 2022;13:869466.","journal-title":"Front Immunol"},{"issue":"6","key":"752_CR11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jaip.2016.08.004","volume":"4","author":"JE Walter","year":"2016","unstructured":"Walter JE, Farmer JR, Foldvari Z, Torgerson TR, Cooper MA. Mechanism-Based strategies for the management of autoimmunity and immune dysregulation in primary immunodeficiencies. J Allergy Clin Immunol Pract. 2016;4(6):1089\u2013100.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"752_CR12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3389\/fimmu.2020.01119","volume":"11","author":"MJ Massaad","year":"2020","unstructured":"Massaad MJ, Zainal M, Al-Herz W. Frequency and manifestations of autoimmunity among children registered in the Kuwait National primary immunodeficiency registry. Front Immunol. 2020;11:1119.","journal-title":"Front Immunol"},{"issue":"10","key":"752_CR13","doi-asserted-by":"publisher","first-page":"e27260","DOI":"10.1002\/pbc.27260","volume":"65","author":"SJ Rotz","year":"2018","unstructured":"Rotz SJ, Ware RE, Kumar A. Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults. Pediatr Blood Cancer. 2018;65(10):e27260.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"752_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1182\/blood.2021013496","volume":"139","author":"C Dhunputh","year":"2022","unstructured":"Dhunputh C, Ducassou S, Fernandes H, Picard C, Rieux-Laucat F, Viallard JF, et al. Abatacept is useful in autoimmune cytopenia with Immunopathologic manifestations caused by CTLA-4 defects. Blood. 2022;139(2):300\u20134.","journal-title":"Blood"},{"issue":"6","key":"752_CR15","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","volume":"7","author":"MG Seidel","year":"2019","unstructured":"Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763\u201370.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"752_CR16","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Sci. 2015;17(5):405\u201324.","journal-title":"Genet Sci"},{"issue":"3","key":"752_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","volume":"27","author":"I Quinti","year":"2007","unstructured":"Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27(3):308\u201316.","journal-title":"J Clin Immunol"},{"issue":"2","key":"752_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/iid3.420","volume":"9","author":"D Zama","year":"2021","unstructured":"Zama D, Conti F, Moratti M, Cantarini ME, Facchini E, Rivalta B, et al. Immune cytopenias as a continuum in inborn errors of immunity: an in-depth clinical and immunological exploration. Immun Inflamm Dis. 2021;9(2):583\u201394.","journal-title":"Immun Inflamm Dis"},{"issue":"1","key":"752_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10875-017-0456-9","volume":"38","author":"EJ Feuille","year":"2018","unstructured":"Feuille EJ, Anooshiravani N, Sullivan KE, Fuleihan RL, Cunningham-Rundles C. Autoimmune cytopenias and associated conditions in CVID: a report from the USIDNET registry. J Clin Immunol. 2018;38(1):28\u201334.","journal-title":"J Clin Immunol"},{"issue":"1","key":"752_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1054\/blre.2001.0185","volume":"16","author":"C Cunningham-Rundles","year":"2002","unstructured":"Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev. 2002;16(1):61\u20134.","journal-title":"Blood Rev"},{"issue":"3","key":"752_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1365-2249.2007.03461.x","volume":"149","author":"C Bacchelli","year":"2007","unstructured":"Bacchelli C, Buckridge S, Thrasher A, Gaspar H. Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency. Clin Experimental Immunol. 2007;149(3):401\u20139.","journal-title":"Clin Experimental Immunol"},{"issue":"9","key":"752_CR22","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","volume":"113","author":"U Salzer","year":"2009","unstructured":"Salzer U, Bacchelli C, Buckridge S, Pan-Hammarstr\u00f6m Q, Jennings S, Lougaris V, et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood. 2009;113(9):1967\u201376.","journal-title":"Blood"},{"issue":"8","key":"752_CR23","first-page":"827","volume":"57","author":"I Kakkas","year":"2021","unstructured":"Kakkas I, Tsinti G, Kalala F, Farmaki E, Kourakli A, Kapousouzi A, et al. TACI mutations in primary antibody deficiencies: a nationwide study in Greece. Med (Kaunas). 2021;57(8):827.","journal-title":"Med (Kaunas)."},{"key":"752_CR24","doi-asserted-by":"publisher","first-page":"1272912","DOI":"10.3389\/fgene.2023.1272912","volume":"14","author":"C Cunningham-Rundles","year":"2024","unstructured":"Cunningham-Rundles C, Casanova J-L, Boisson B. Genetics and clinical phenotypes in common variable immunodeficiency. Front Genet. 2024;14:1272912.","journal-title":"Front Genet"},{"key":"752_CR25","doi-asserted-by":"publisher","first-page":"622114","DOI":"10.3389\/fimmu.2020.622114","volume":"11","author":"EM Matson","year":"2020","unstructured":"Matson EM, Abyazi ML, Bell KA, Hayes KM, Maglione PJ. B cell dysregulation in common variable immunodeficiency interstitial lung disease. Front Immunol. 2020;11:622114.","journal-title":"Front Immunol"},{"issue":"2","key":"752_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","volume":"35","author":"SE Aydin","year":"2015","unstructured":"Aydin SE, Kilic SS, Aytekin C, Kumar A, Porras O, Kainulainen L, et al. DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients. J Clin Immunol. 2015;35(2):189\u201398.","journal-title":"J Clin Immunol"},{"issue":"1","key":"752_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10875-012-9769-x","volume":"33","author":"Z Alsum","year":"2013","unstructured":"Alsum Z, Hawwari A, Alsmadi O, Al-Hissi S, Borrero E, Abu-Staiteh A, et al. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients. J Clin Immunol. 2013;33(1):55\u201367.","journal-title":"J Clin Immunol"},{"issue":"8","key":"752_CR28","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/j.jaip.2019.06.011","volume":"7","author":"A Kiykim","year":"2019","unstructured":"Kiykim A, Ogulur I, Dursun E, Charbonnier LM, Nain E, Cekic S, et al. Abatacept as a Long-Term targeted therapy for LRBA deficiency. J Allergy Clin Immunol Pract. 2019;7(8):2790\u2013e80015.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"752_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5114\/ceji.2014.42135","volume":"39","author":"I Osi\u0144ska","year":"2014","unstructured":"Osi\u0144ska I, Popko K, Demkow U. Perforin: an important player in immune response. Cent Eur J Immunol. 2014;39(1):109\u201315.","journal-title":"Cent Eur J Immunol"},{"issue":"5","key":"752_CR30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","volume":"38","author":"I Meyts","year":"2018","unstructured":"Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38(5):569\u201378.","journal-title":"J Clin Immunol"},{"key":"752_CR31","doi-asserted-by":"publisher","first-page":"926087","DOI":"10.3389\/fimmu.2022.926087","volume":"13","author":"W Zheng","year":"2022","unstructured":"Zheng W, Fan X, Yang Z, Shangguan Y, Jin T, Liu Y, et al. Strong inflammatory signatures in the neutrophils of PAMI syndrome. Front Immunol. 2022;13:926087.","journal-title":"Front Immunol"},{"issue":"7","key":"752_CR32","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650\u20137.","journal-title":"Blood"},{"issue":"5","key":"752_CR33","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","volume":"99","author":"K Warnatz","year":"2002","unstructured":"Warnatz K, Denz A, Dr\u00e4ger R, Braun M, Groth C, Wolff-Vorbeck G, et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002;99(5):1544\u201351.","journal-title":"Blood"},{"issue":"5","key":"752_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1023\/A:1025373601374","volume":"23","author":"B Piqueras","year":"2003","unstructured":"Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23(5):385\u2013400.","journal-title":"J Clin Immunol"},{"issue":"1","key":"752_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77\u201385.","journal-title":"Blood"},{"issue":"3","key":"752_CR36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.clim.2008.02.013","volume":"128","author":"S S\u00e1nchez-Ram\u00f3n","year":"2008","unstructured":"S\u00e1nchez-Ram\u00f3n S, Radigan L, Yu JE, Bard S, Cunningham-Rundles C. Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol. 2008;128(3):314\u201321.","journal-title":"Clin Immunol"},{"issue":"5","key":"752_CR37","first-page":"323","volume":"23","author":"H Abolhassani","year":"2013","unstructured":"Abolhassani H, Amirkashani D, Parvaneh N, Mohammadinejad P, Gharib B, Shahinpour S, et al. Autoimmune phenotype in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2013;23(5):323\u20139.","journal-title":"J Investig Allergol Clin Immunol."},{"issue":"2","key":"752_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clim.2009.03.519","volume":"132","author":"J Genre","year":"2009","unstructured":"Genre J, Errante PR, Kokron CM, Toledo-Barros M, C\u00e2mara NO, Rizzo LV. Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity? Clin Immunol. 2009;132(2):215\u201321.","journal-title":"Clin Immunol."}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00752-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-025-00752-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00752-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:34:36Z","timestamp":1758738876000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-025-00752-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1186\/s12865-025-00752-1","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"This study received approval from the Ethics Committee of Necmettin Erbakan University Faculty of Medicine (Approval Number: 23374.R1 Date: March 7 2025). Written informed consent was obtained from all participants in the study, in accordance with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}}],"article-number":"66"}}